NYSE:A - Agilent Technologies Stock Price, Forecast & News Adding Choose a watchlist: Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat Daily Premium to add more stocks to your watchlist. Adding Agilent Technologies Inc Please log in to your account or sign up in order to add this asset to your watchlist. Log In and Add $90.12 +0.66 (+0.74 %) (As of 01/19/2020 04:00 PM ET) Add Compare Today's Range$89.21Now: $90.12▼$90.2850-Day Range$80.11MA: $84.60▼$90.1252-Week Range$65.35Now: $90.12▼$90.28Volume3.72 million shsAverage Volume1.23 million shsMarket Capitalization$27.95 billionP/E Ratio26.82Dividend Yield0.80%Beta1.42 ProfileAnalyst RatingsAdvanced ChartDividendEarningsFinancialsInsider TradesInstitutional OwnershipHeadlinesOptions ChainSEC FilingsSocial Media Share on FacebookShare on TwitterShare on LinkedInShare on RedditShare on StocktwitsPrint this articleShare by Email Agilent Technologies, Inc provides application focused solutions to the life sciences, diagnostics, and applied chemical markets worldwide. It operates through three segments: Life Sciences and Applied Markets, Diagnostics and Genomics, and Agilent CrossLab. The Life Sciences and Applied Markets segment offers liquid chromatography systems and components; liquid chromatography mass spectrometry systems; gas chromatography systems and components; gas chromatography mass spectrometry systems; inductively coupled plasma mass spectrometry instruments; atomic absorption instruments; microwave plasma-atomic emission spectrometry instruments; inductively coupled plasma optical emission spectrometry instruments; raman spectroscopy; cell analysis plate based assays; flow cytometer; real-time cell analyzer; laboratory software and information management and analytics; laboratory automation and robotic systems; dissolution testing; vacuum pumps; and measurement technologies. Read More… Industry, Sector and Symbol Stock Exchange NYSE Industry Analytical instruments Sub-IndustryLife Sciences Tools & Services SectorComputer and Technology Current SymbolNYSE:A Previous Symbol CUSIP00846U10 CIK1090872 Webhttp://www.agilent.com/ Phone800-227-9770Debt Debt-to-Equity Ratio0.38 Current Ratio1.53 Quick Ratio1.21Price-To-Earnings Trailing P/E Ratio26.82 Forward P/E Ratio26.43 P/E Growth2.1 Sales & Book Value Annual Sales$5.16 billion Price / Sales5.41 Cash Flow$3.99 per share Price / Cash Flow22.56 Book Value$15.34 per share Price / Book5.87Profitability EPS (Most Recent Fiscal Year)$3.11 Net Income$1.07 billion Net Margins20.74% Return on Equity20.13% Return on Assets10.97%Miscellaneous Employees16,300 Outstanding Shares310,180,000Market Cap$27.95 billion Next Earnings Date2/19/2020 (Estimated) OptionableOptionable Receive A News and Ratings via Email Sign-up to receive the latest news and ratings for A and its competitors with MarketBeat's FREE daily newsletter. A Rates by TradingView Agilent Technologies (NYSE:A) Frequently Asked Questions What is Agilent Technologies' stock symbol? Agilent Technologies trades on the New York Stock Exchange (NYSE) under the ticker symbol "A." How often does Agilent Technologies pay dividends? What is the dividend yield for Agilent Technologies? Agilent Technologies announced a quarterly dividend on Wednesday, November 20th. Investors of record on Tuesday, December 31st will be paid a dividend of $0.18 per share on Wednesday, January 22nd. This represents a $0.72 dividend on an annualized basis and a dividend yield of 0.80%. The ex-dividend date is Monday, December 30th. This is a positive change from Agilent Technologies's previous quarterly dividend of $0.16. View Agilent Technologies' Dividend History. How will Agilent Technologies' stock buyback program work? Agilent Technologies announced that its Board of Directors has authorized a share buyback plan on Monday, November 19th 2018, which allows the company to buyback $1,750,000,000.00 in shares, according to EventVestor. This buyback authorization allows the company to reacquire up to 8.8% of its stock through open market purchases. Stock buyback plans are typically a sign that the company's management believes its stock is undervalued. How were Agilent Technologies' earnings last quarter? Agilent Technologies Inc (NYSE:A) issued its earnings results on Monday, November, 25th. The medical research company reported $0.89 earnings per share (EPS) for the quarter, beating the Zacks' consensus estimate of $0.86 by $0.03. The medical research company earned $1.37 billion during the quarter, compared to analyst estimates of $1.33 billion. Agilent Technologies had a return on equity of 20.13% and a net margin of 20.74%. The firm's quarterly revenue was up 5.6% on a year-over-year basis. During the same period in the prior year, the firm posted $0.81 earnings per share. View Agilent Technologies' Earnings History. When is Agilent Technologies' next earnings date? Agilent Technologies is scheduled to release their next quarterly earnings announcement on Wednesday, February 19th 2020. View Earnings Estimates for Agilent Technologies. What guidance has Agilent Technologies issued on next quarter's earnings? Agilent Technologies updated its FY20 earnings guidance on Monday, November, 25th. The company provided earnings per share (EPS) guidance of $3.38-3.43 for the period, compared to the Thomson Reuters consensus estimate of $3.44. The company issued revenue guidance of $5.50-5.55 billion, compared to the consensus revenue estimate of $5.55 billion. What price target have analysts set for A? 13 brokerages have issued 12-month target prices for Agilent Technologies' stock. Their forecasts range from $76.00 to $100.00. On average, they expect Agilent Technologies' share price to reach $85.31 in the next year. This suggests that the stock has a possible downside of 5.3%. View Analyst Price Targets for Agilent Technologies. What is the consensus analysts' recommendation for Agilent Technologies? 13 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Agilent Technologies in the last year. There are currently 5 hold ratings and 8 buy ratings for the stock, resulting in a consensus recommendation of "Buy." View Analyst Ratings for Agilent Technologies. What are Wall Street analysts saying about Agilent Technologies stock? Here are some recent quotes from research analysts about Agilent Technologies stock: 1. According to Zacks Investment Research, "Agilent reported strong fiscal third-quarter results on broad-based growth in all its product lines. The company also raised its guidance for full year 2019. The company’s expanding product portfolio, end-market strength and robust performance in Americas, China and Europe are key growth drivers. Moreover, the company’s decision to divest/wind up underperforming businesses is beneficial for its core operations. Further, the company’s focus on aligning investments towards more attractive growth avenues and innovative high-margin product launches are positive. Notably, shares of Agilent have outperformed the industry it belongs to over a year. However, macro weakness in some regions, higher expenses and unfavorable foreign exchange remain concerns." (8/19/2019) 2. Barclays PLC analysts commented, "We think Agilent delivered a solid FY1Q19 print last night, featuring a modest top line beat which was leveraged into a 6% EPS beat ($0.76 vs. our $0.72 forecast). Consistent trends help improve our conviction in the thesis heading into FY2019. Organic growth of 6% in the quarter came in 1.2% better than our expectations and guidance. Growth was solid, although less broad-based than last quarter – which we view as understandable in the context of tough quarterly comps. Notably, DGG posted 13% organic growth while ACG delivered 10% organic growth. The capital equipment driven LSAG division posted just" 1% organic growth, but on an 11% quarterly comp. From an end market perspective, we think results hit the mark across customer classes and geographies. Pharma & Sales) posted 10% core growth." (2/21/2019) Has Agilent Technologies been receiving favorable news coverage? Media coverage about A stock has trended very negative on Sunday, InfoTrie Sentiment reports. InfoTrie identifies positive and negative news coverage by monitoring more than six thousand blog and news sources in real-time. The firm ranks coverage of public companies on a scale of negative five to positive five, with scores closest to five being the most favorable. Agilent Technologies earned a daily sentiment score of -3.0 on InfoTrie's scale. They also assigned news articles about the medical research company a news buzz of 0.0 out of 10, meaning that recent news coverage is extremely unlikely to have an impact on the company's share price in the next few days. View News Stories for Agilent Technologies. Are investors shorting Agilent Technologies? Agilent Technologies saw a decrease in short interest during the month of December. As of December 31st, there was short interest totalling 4,660,000 shares, a decrease of 9.2% from the December 15th total of 5,130,000 shares. Based on an average daily trading volume, of 1,570,000 shares, the short-interest ratio is presently 3.0 days. Currently, 1.5% of the shares of the company are short sold. View Agilent Technologies' Current Options Chain. Who are some of Agilent Technologies' key competitors? Some companies that are related to Agilent Technologies include Thermo Fisher Scientific (TMO), Illumina (ILMN), Mettler-Toledo International (MTD), Waters (WAT), Bio-Rad Laboratories (BIO), PerkinElmer (PKI), BIO-TECHNE (TECH), Bruker (BRKR), Charles River Laboratories Intl. (CRL), Cambrex (CBM), Luminex (LMNX), Pacific Biosciences of California (PACB), Fluidigm (FLDM), Harvard Bioscience (HBIO) and aTyr Pharma (LIFE). What other stocks do shareholders of Agilent Technologies own? Based on aggregate information from My MarketBeat watchlists, some companies that other Agilent Technologies investors own include AbbVie (ABBV), NVIDIA (NVDA), Alibaba Group (BABA), AT&T (T), Netflix (NFLX), Walt Disney (DIS), Boeing (BA), Paypal (PYPL), Intel (INTC) and Broadcom (AVGO). Who are Agilent Technologies' key executives? Agilent Technologies' management team includes the folowing people: Mr. Michael R. McMullen, CEO, Pres & Director (Age 58)Mr. Robert W. McMahon, Sr. VP & CFO (Age 50)Mr. Dominique P. Grau, Sr. VP of HR (Age 60)Mr. Mark Doak, Sr. VP (Age 64)Mr. Jacob Thaysen, Sr. VP (Age 44) Who are Agilent Technologies' major shareholders? Agilent Technologies' stock is owned by many different of institutional and retail investors. Top institutional shareholders include LGT Capital Partners LTD. (0.19%), Calamos Advisors LLC (0.16%), Hexavest Inc. (0.15%), Hahn Capital Management LLC (0.12%), Commerzbank Aktiengesellschaft FI (0.06%) and Artemis Investment Management LLP (0.05%). Company insiders that own Agilent Technologies stock include Boon Hwee Koh, Dominique Grau, Heidi Fields, Mark Doak, Michael R Mcmullen, Michael Tang, Patrick G Hagan, Patrick Kaltenbach, Paul N Clark and Rodney Gonsalves. View Institutional Ownership Trends for Agilent Technologies. Which institutional investors are selling Agilent Technologies stock? A stock was sold by a variety of institutional investors in the last quarter, including State of Alaska Department of Revenue, Meag Munich Ergo Kapitalanlagegesellschaft MBH, Boston Trust Walden Corp, Hahn Capital Management LLC, Sciencast Management LP, Calamos Advisors LLC, Commerzbank Aktiengesellschaft FI and IFM Investors Pty Ltd. Company insiders that have sold Agilent Technologies company stock in the last year include Dominique Grau, Heidi Fields, Mark Doak, Michael R Mcmullen, Michael Tang, Paul N Clark and Rodney Gonsalves. View Insider Buying and Selling for Agilent Technologies. Which institutional investors are buying Agilent Technologies stock? A stock was purchased by a variety of institutional investors in the last quarter, including Hexavest Inc., Artemis Investment Management LLP, PGGM Investments, LGT Capital Partners LTD., Johanson Financial Advisors Inc., DNB Asset Management AS, AE Wealth Management LLC and Fruth Investment Management. View Insider Buying and Selling for Agilent Technologies. How do I buy shares of Agilent Technologies? Shares of A can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity and Charles Schwab. What is Agilent Technologies' stock price today? One share of A stock can currently be purchased for approximately $90.12. How big of a company is Agilent Technologies? Agilent Technologies has a market capitalization of $27.95 billion and generates $5.16 billion in revenue each year. The medical research company earns $1.07 billion in net income (profit) each year or $3.11 on an earnings per share basis. Agilent Technologies employs 16,300 workers across the globe.View Additional Information About Agilent Technologies. What is Agilent Technologies' official website? The official website for Agilent Technologies is http://www.agilent.com/. How can I contact Agilent Technologies? Agilent Technologies' mailing address is 5301 STEVENS CREEK BLVD, SANTA CLARA CA, 95051. The medical research company can be reached via phone at 800-227-9770 or via email at [email protected] MarketBeat Community Rating for Agilent Technologies (NYSE A)Community Ranking: 3.0 out of 5 ( )Outperform Votes: 727 (Vote Outperform)Underperform Votes: 486 (Vote Underperform)Total Votes: 1,213MarketBeat's community ratings are surveys of what our community members think about Agilent Technologies and other stocks. Vote "Outperform" if you believe A will outperform the S&P 500 over the long term. Vote "Underperform" if you believe A will underperform the S&P 500 over the long term. You may vote once every thirty days. This page was last updated on 1/19/2020 by MarketBeat.com StaffFeatured Article: How is a buy-side analyst different from a sell-side analyst?
